Cargando…
A Lung Cancer Patient with Dyspnea: Diagnostic Difficulties during the COVID-19 Pandemic
Autores principales: | Pruis, Melinda A., Hussain, Burhan, Bakker, Marleen, Hoek, Rogier A.S., Miedema, Jelle R., Dingemans, Anne-Marie C., Paats, Marthe S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546267/ https://www.ncbi.nlm.nih.gov/pubmed/33068525 http://dx.doi.org/10.1016/j.ccell.2020.10.005 |
Ejemplares similares
-
Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer: Outcomes of Cardio-Oncology Follow-Up
por: Pruis, Melinda A., et al.
Publicado: (2023) -
Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course
por: Miedema, Jelle, et al.
Publicado: (2021) -
Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer: how to treat and when?
por: Schoenmaekers, Janna Josephus Anna Oda, et al.
Publicado: (2020) -
From Dyspnea to Skin Grafting: The Difficulties of Managing a Patient with Extreme Obesity
por: Lambert, Flora, et al.
Publicado: (2022) -
Defining oligometastatic non-small cell lung cancer: concept versus biology, a literature review
por: Mentink, Jill F., et al.
Publicado: (2021)